Oral adherence in adults with acute myeloid leukemia (AML): results of a mixed methods study
- 14 February 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 28 (11), 5157-5164
- https://doi.org/10.1007/s00520-020-05349-5
Abstract
Introduction The incidence of AML is increasing, in part due to an aging population. Since 2017, eight novel agents have been introduced, 6 of which are oral: midostaurin, enasidenib, ivosidenib, gilteritinib, glasdegib, and venetoclax. With an increase in oral medications (OMs), patients face associated side effects that accompany OMs, which often decreases adherence. We aimed to identify and summarize adherence to OMs in this population. Methods Our mixed method design used focus groups (FG) and patient surveys. After IRB approval, 11 patients and 4 caregivers participated in 4 FGs. Themes from the FGs were used to develop a 37-item OMs adherence needs assessment. Participants were recruited and consented at three cancer centers to complete surveys (online, at the clinic, hospital, or from home). Results A total of 100 patients completed OMs survey. The number of pills to be taken was the most frequent and troublesome challenge. The most frequently reported interventions that would improve patient adherence were smaller pills, easier packaging, and scheduling assistance. Nearly 33% of patients indicated they skip OMs dose altogether when they forget to take it. Younger patients (< 65 years) were more accepting of taking oral compared with intravenous medications (p = .03). Conclusion This study represents the first assessment of OMs adherence in adults with AML. Findings provide the basis for further exploration of interventions to enhance and increase adherence to OMs regimens.Funding Information
- Astellas, Inc (None)
This publication has 11 references indexed in Scilit:
- Symptoms, Mobility and Function, and Quality of Life in Adults With Acute Leukemia During Initial HospitalizationOncology Nursing Forum, 2018
- ESPACOMP Medication Adherence Reporting Guideline (EMERGE)Annals of Internal Medicine, 2018
- Use of a Smartphone Application for Prompting Oral Medication Adherence Among Adolescents and Young Adults With CancerOncology Nursing Forum, 2018
- Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendationsCancer Treatment Reviews, 2017
- A Systematic Review of Adherence to Oral Antineoplastic TherapiesThe Oncologist, 2016
- Prevention of Nausea and Vomiting in Patients Undergoing Oral Anticancer Therapies for Solid TumorsBioMed Research International, 2015
- Patient-Reported Symptoms and Quality of Life in Adults With Acute Leukemia: A Systematic ReviewOncology Nursing Forum, 2015
- Physiologic and Psychological Symptoms Experienced by Adults With Acute Leukemia: An Integrative Literature ReviewOncology Nursing Forum, 2014
- Smartphone medication adherence apps: Potential benefits to patients and providersJournal of the American Pharmacists Association, 2013
- Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO studyBlood, 2009